http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-201806309-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffbe71cb54b92414ad178bb647126c1d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
filingDate 2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b916b7b625bea15e747b6227c244a68d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c46442fbb184b4b12ee26b36d6b9e43e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11c25e5a2d2d6507edddcb1ef54a5c84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6637b24d9c78168dc31848682211b7db
publicationDate 2018-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TR-201806309-A2
titleOfInvention SOLID ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING DABIGATRAN ETEXCLATE
abstract The present invention relates to solid oral pharmaceutical compositions comprising dabigatran etexylate free base or pharmaceutically acceptable salts, polymorphs, solvates, hydrates or esters of dabigatran etexylate.
priorityDate 2017-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135565674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479912

Total number of triples: 23.